We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy.
- Authors
Ferrannini, E; Fonseca, V; Zinman, B; Matthews, D; Ahrén, B; Byiers, S; Shao, Q; Dejager, S
- Abstract
To examine the efficacy and safety of vildagliptin vs. glimepiride as add-on therapy to metformin in patients with type 2 diabetes mellitus in a 52-week interim analysis of a large, randomized, double-blind, multicentre study. The primary objective was to demonstrate non-inferiority of vildagliptin vs. glimepiride in glycosylated haemoglobin (HbA(1c)) reduction at week 52.
- Publication
Diabetes, obesity & metabolism, 2009, Vol 11, Issue 2, p157
- ISSN
1463-1326
- Publication type
Journal Article
- DOI
10.1111/j.1463-1326.2008.00994.x